Medical Xpress10h
Treatment target for aggressive leukemia discovered by disrupting its genome organization
The research is published in The EMBO Journal. AML remains a challenging cancer to treat AML's complexity makes it a ...
Inhibiting METTL3 protein shows promise for high-risk neuroblastoma
Blocking the METTL3 protein can increase sensitivity to chemotherapy in neuroblastoma, according to research from the ...
icr.ac.uk17h
New treatment target for aggressive leukaemia discovered by disrupting its genome organisation
Researchers have identified a key weakness in acute myeloid leukaemia, offering a promising new strategy to delay the ...
Bunkered12h
New inquiry starts over controversial Scottish golf course
A four-day inquiry has started this week over proposals for a controversial new championship golf course in Scotland.
Beth Israel Deaconess Medical Center10h
Study Reveals Disconnect in Medical Device Use and Urges Action on Cardiac Care Inequities
Cardiologists from BIDMC, commissioned by the FDA, examined trends in the use and long-term safety of a device for treating ...
Computational method pinpoints how cause-and-effect relationships ebb and flow over time
A new computational method can identify how cause-and-effect relationships ebb and flow over time in dynamic real-life ...
eLife11h
Endophilin A1 facilitates organization of the GABAergic postsynaptic machinery to maintain excitation-inhibition balance
This study presents a valuable finding on the molecular mechanisms that govern GABAergic inhibitory synapse function. The authors propose that Endophilin A1 serves as a novel regulator of GABAergic ...